Significance of cd271 in bone marrow mesenchymal stem cells-changes by cryopreservation

Journal of Craniofacial Surgery

Volumn 21, Issue 3, 2010, Pages 666-678

  Aoyagi, Kazuya ^a   Yamazaki, Yasuharu ^a   Matsuo, Aoi ^a   Shimakura, Yasuhito ^a   Takeda, Akira ^a   Uchinuma, Eiju ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

CD271; Cryopreserve; Mesenchymal stem cells

Indexed keywords

ALCAM PROTEIN, HUMAN; BIOLOGICAL MARKER; CD133 ANTIGEN; CD27 ANTIGEN; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; FETOPROTEIN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; NERVE CELL ADHESION MOLECULE; PEPTIDE;

BONE MARROW CELL; BONE TRANSPLANTATION; CLEFT LIP; CLEFT PALATE; CONFERENCE PAPER; CRYOPRESERVATION; CYTOLOGY; HUMAN; MESENCHYMAL STEM CELL; METABOLISM;

ANTIGENS, CD; ANTIGENS, CD27; BIOLOGICAL MARKERS; BONE MARROW CELLS; BONE TRANSPLANTATION; CELL ADHESION MOLECULES, NEURONAL; CLEFT LIP; CLEFT PALATE; CRYOPRESERVATION; FETAL PROTEINS; GLYCOPROTEINS; HUMANS; MESENCHYMAL STEM CELLS; PEPTIDES; RECEPTORS, CELL SURFACE;

EID: 77952871515     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e3181d7a792     Document Type: Conference Paper

References (24)

1. Shimakura Y, Yamazaki Y, Uchinuma E, et al. Experimental study on bone formation potential of cryopreserved human bone marrow mesenchymal cell/hydroxyapatite complex in the presence of recombinant human bone morphogenetic protein-2. J Craniofac Surg 2003;14:108-116
2. Matsuo A, Yamazaki Y, Aoyagi K, et al. Osteogenic potential of cryopreserved human bone marrow-derived mesenchymal stem cells cultured with autologous serum. J Craniofac Surg 2008;19:693-700
3. Friedenstein AJ, Gorskaja JF, Kulagina NN, et al. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976;4:267-274
4. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147
5. Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90: 5002-5012
6. Uchida N, Buck DW, He D, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 2000;97: 14720-14725
7. Handgretinger R, Gordon PR, Leimig T, et al. Biology and plasticity of CD133+ hematopoietic stem cells. Ann N Y Acad Sci 2003;996: 141-151
8. Tondreau T, Meuleman N, Delforge A, et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 2005;23:1105-1112
9. Gindraux F, Selmani Z, Obert L, et al. Human and rodent bone marrow mesenchymal stem cells that express primitive stem cell markers can be directly enriched by using the CD49a molecule. Cell Tissue Res 2007;327:471-483
10. Yu Y, Fuhr J, Boye E, et al. Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells 2006;24:1605-1612
11. Haynesworth SE, Baber MA, Caplan AI. Cell surface antigens on human marrowYderived mesenchymal cells are detected by monoclonal antibodies. Bone 1992;13:69-80
12. Barry FP, Boynton RE, Haynesworth S, et al. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun 1999;265:134-139
13. Bruder SP, Horowitz MC, Mosca JD, et al. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone 1997;21:225-235
14. Bruder SP, Ricalton NS, Boynton RE, et al. Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation. J Bone Miner Res 1998;13:655-663
15. Thomson TM, Rettig WJ, Chesa PG, et al. Expression of human nerve growth factor receptor on cells derived from all three germ layers. Exp Cell Res 1988;174:533-539
16. Chesa PG, Rettig WJ, Thomson TM, et al. Immunohistochemical analysis of nerve growth factor receptor expression in normal and malignant human tissues. J Histochem Cytochem 1988;36:383-389
17. Thompson SJ, Schatteman GC, Gown AM, et al. A monoclonal antibody against nerve growth factor receptor. Immunohistochemical analysis of normal and neoplastic human tissue. Am J Clin Pathol 1989; 92:415-423
18. Cattoretti G, Schiro R, Orazi A, et al. Bone marrow stroma in humans: antiYnerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro. Blood 1993;81:1726-1738
19. Jones EA, Kinsey SE, English A, et al. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002;46:3349-3360
20. Wong GL, Ng MC, Calabrese DW, et al. Characterization of bone cells isolated on discontinuous Percoll gradients: distribution in sequentially derived populations. J Bone Miner Res 1991;6:969-976
21. Bühring HJ, Battula VL, Treml S, et al. Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci 2007;1106:262-271
22. Quirici N, Soligo D, Bossolasco P, et al. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 2002;30:783-791
23. Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997;64:278-294
24. Bertram H, Mayer H, Schliephake H. Effect of donor characteristics, technique of harvesting and in vitro processing on culturing of human marrow stroma cells for tissue engineered growth of bone. Clin Oral Implants Res 2005;16:524-531